Literature DB >> 27957183

Optimization Of Stroke Prophylaxis Strategies In Nonvalvular AF -Drugs, Devices Or Both?

Amit Noheria1, Faisal F Syed1, Christopher V DeSimone1, Samuel J Asirvatham2.   

Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia with the prevalence increasing over time. AF probably afflicts ≥2% of worldwide adult population and increases with age.[1-3] In the Framingham Heart Study, the lifetime risk of having at least one episode of AF for 40-year-old men and women was 26% and 23% respectively.[4].

Entities:  

Keywords:  Anticoagulation; Defibrillation; Device; Stroke

Year:  2015        PMID： 27957183      PMCID： PMC4833393          DOI： 10.4022/jafib.1156

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN： 1941-6911


  99 in total

1.  Transcatheter patch occlusion of the left atrial appendage using surgical adhesives in high-risk patients with atrial fibrillation.

Authors:  Savvas Toumanides; Eleftherios B Sideris; Tullio Agricola; Spyridon Moulopoulos
Journal:  J Am Coll Cardiol       Date:  2011-11-15       Impact factor: 24.094

2.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation.

Authors:  Sakis Themistoclakis; Andrea Corrado; Francis E Marchlinski; Pierre Jais; Erica Zado; Antonio Rossillo; Luigi Di Biase; Robert A Schweikert; Walid I Saliba; Rodney Horton; Prasant Mohanty; Dimpi Patel; David J Burkhardt; Oussama M Wazni; Aldo Bonso; David J Callans; Michel Haissaguerre; Antonio Raviele; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2010-02-23       Impact factor: 24.094

3.  Safe, effective and durable epicardial left atrial appendage clip occlusion in patients with atrial fibrillation undergoing cardiac surgery: first long-term results from a prospective device trial.

Authors:  Maximilian Y Emmert; Gilbert Puippe; Stephan Baumüller; Hatem Alkadhi; Ulf Landmesser; Andre Plass; Dominique Bettex; Jacques Scherman; Jürg Grünenfelder; Michele Genoni; Volkmar Falk; Sacha P Salzberg
Journal:  Eur J Cardiothorac Surg       Date:  2013-05-08       Impact factor: 4.191

4.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Europace       Date:  2012-08-24       Impact factor: 5.214

5.  Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.

Authors:  Stefan H Ostermayer; Mark Reisman; Paul H Kramer; Ray V Matthews; William A Gray; Peter C Block; Heyder Omran; Antonio L Bartorelli; Paolo Della Bella; Carlo Di Mario; Carlo Pappone; Paul N Casale; Jeffrey W Moses; Athena Poppas; David O Williams; Bernhard Meier; Allan Skanes; Paul S Teirstein; Michael D Lesh; Toshiko Nakai; Yves Bayard; Kai Billinger; Thomas Trepels; Ulrike Krumsdorf; Horst Sievert
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

6.  Left atrial dysfunction in patients with atrial fibrillation after successful rhythm control for > 3 months.

Authors:  Yi-Chih Wang; Jiunn-Lee Lin; Juey-Jen Hwang; Mao-Shin Lin; Chuen-Den Tseng; Shoei K Stephen Huang; Ling-Ping Lai
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

7.  Survival after stroke--the impact of CHADS2 score and atrial fibrillation.

Authors:  Karin M Henriksson; Bahman Farahmand; Saga Johansson; Signild Asberg; Andreas Terént; Nils Edvardsson
Journal:  Int J Cardiol       Date:  2009-01-13       Impact factor: 4.164

8.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

9.  Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.

Authors:  M D Ezekowitz; K E James; S M Nazarian; J Davenport; J P Broderick; S R Gupta; V Thadani; M L Meyer; S L Bridgers
Journal:  Circulation       Date:  1995-10-15       Impact factor: 29.690

10.  Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.

Authors:  Sheldon M Singh; Andrew Micieli; Harindra C Wijeysundera
Journal:  Circulation       Date:  2013-05-22       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.